The Home Office ran a consultation on the scheduling of tramadol under the Misuse of Drugs Regulations 2001. This followed a Ministerial decision, in principle, to accept the ACMD's…
MHRA (Medicines and Healthcare Products Regulatory Agency) ran a consultation on the continued availability of diclofenac as a Pharmacy (P) medicine and on the risk minimisation…
HEFCE (Higher Education Funding Council for England) ran a consultation on open access requirements for the post-2014 REF (following on from the informal request for advice in…
The Commons Select Science and Technology Committee held an inquiry into antimicrobial resistance. BPS responded to highlight the need to incentivise development of new…
The National Institute for Health and Care Excellence (NICE) has consulted on the scope (i.e. what aspects of care the guideline will cover and to whom it will apply) of the clinical…
The Welsh Government recently sought comments on a series of recommendations for the improvement of the appraisal process of orphan and ultra-orphan medicines in Wales. The Society…
This consultation set out the National Institute for Health and Care Excellence's (NICE) proposals to enhance the information and support currently offered by the British National…
Health Education England (HEE) consulted on the NHS workforce in England. This consultation sought input regarding investment in the future workforce (i.e. decisions regarding…
The Advisory Panel on Substance Misuse (APoSM) was invited to review the Welsh Government policy response to the increase in drug-related deaths related to tramadol and other…
Research Councils UK (RCUK) has conducted the first review of its open access policy. The Society responded to highlight the current impact on learned societies, and the uptake and…
